Why 2026 Is a Defining Year for RNA-Targeted Drug Discovery
The RNA-targeted small molecule field is entering a pivotal stage of growth.
With more clinical-stage programs, increasing pharma investment, expanding partnership activity, and growing confidence in RNA as a druggable target, the industry is moving beyond proof-of-concept toward therapeutic validation.
At the 9th RNA-Targeted Drug Discovery & Development Summit, discover the latest advances, connect with the companies driving momentum, and explore the scientific breakthroughs shaping the future of the field.
Meet the New Organizations Joining Us in 2026
As momentum across the RNA-targeted small molecule space continues to grow, we're welcoming new biotech pioneers, pharma leaders, and academic innovators to this year's summit.
Discover fresh perspectives, new partnership opportunities, and scientific insights from organizations helping shape the future of RNA-targeted therapeutics.
Why Attend in 2026?
Hear new insights from companies advancing RNA-targeted programs toward the clinic
Explore emerging modalities beyond splice modulation, including degraders, covalent binders, and induced-proximity approaches
Understand how leading teams are improving target selection, validation, and selectivity
Connect with biotech pioneers, pharma leaders, and academic innovators shaping the future of RNA therapeutics
Benchmark your strategy against the organizations driving the next wave of clinical progress
New Scientific Priorities for 2026
This year's agenda expands beyond traditional splice modulation to explore the next generation of RNA-targeting approaches, including:
Direct RNA binding
RNA degradation
Covalent translation inhibition
Induced-proximity strategies
Epitranscriptomic regulation
Structure-guided design
AI-enabled target identification
As the field matures, the focus is shifting from demonstrating RNA engagement to delivering meaningful therapeutic outcomes.
Showcase Your Science to the RNA Community
Whether you're advancing a novel platform, exploring new chemistry, or generating breakthrough biological insights, the Scientific Poster Session is your opportunity to share your work with the researchers, innovators, and decision-makers shaping the future of RNA-targeted therapeutics.
Why Present a Poster?
- Gain visibility among biotech and pharma leaders
- Receive feedback from scientific peers
- Start new collaborations and partnerships
- Generate discussion around emerging research
- Position your work within the leading RNA-targeted small molecule community
When is the Scientific Poster Session?
It will be held on Wednesday, November 11 at 2:30pm (Conference Day 1).
How to Submit Your Poster
First Register Your Place To Attend
Submit an abstract for review to showcase your poster during the Scientific Poster Session
You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit.
What Are Key Sessions You Shouldn't Miss?
Exploring How Chemically Diverse Fragments Target a Cryptic RNA Binding Pocket through Base Displacement
Advancing Oral Splice-Modulating Small Molecules Toward Clinical Development for Rare Neurodegenerative Diseases
Optimization & Functional Characterization of MYC RNA-Targeting Small Molecules
Rational, Structure-Guided Design of Small Molecule Covalent Translation Inhibitors Targeting mRNA
Modelling Approaches to Understand RNA Structure, Dynamics, & Small Molecule Binding to Guide Target Selection & Improve Small Molecule Design
Bring Your Entire Team
The challenges facing RNA-targeted drug discovery increasingly require collaboration across biology, chemistry, computational science, and translational development.
Bring your colleagues across:
- Computational Biology/AI
- Biophysics
- RNA Biology
- Drug Discovery
- Medicinal Chemistry
- Structural Biology
- Chemical Biology
- Translational Research
- Pharmacology
- Screening & Assay Development
- Business Development
Learn together, benchmark together, and align around the emerging opportunities shaping the future of RNA-targeted therapeutics.
See Everything New for 2026
Download the Event Guide to:
- Explore the complete agenda
- View all confirmed speakers
- Discover new companies attending
- Access workshop details
- Identify the sessions most relevant to your role
- Plan your networking opportunities
Explore the Agenda
Hear the latest industry advances in RNA target selection, structure-guided design, selective modulation and translational strategies across the full RNA-targeted small molecule pipeline and during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Connect with RNA-targeted small molecule leaders across discovery, preclinical and clinical development during our dedicated networking sessions to exchange insights, build collaborations and strengthen decisions from target selection to therapeutic impact.